Comparison of sodium-glucose cotransporter-2 (SGLT2) inhibitors to reduce cardiovascular and renal outcomes: a network meta-analysis of randomized controlled trials

被引：0
作者：
Kani, R. [1 ]
Watanabe, A. [2 ]
Miyamoto, Y. [3 ]
Kuno, T. [4 ]
机构：
[1] Kameda Med Ctr, Kamogawa, Japan
[2] Univ Tsukuba, Div Hosp Med, Ibaraki, Japan
[3] Ctr Dis Control & Prevent, Div Diabet Translat, Surveillance Econ & Stat Branch, Atlanta, GA USA
[4] Albert Einstein Coll Med, Div Cardiol, Montefiore Med Ctr, New York, NY USA
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
[21]   Comparative effectiveness of cardiovascular outcomes in new users of sodium-glucose cotransporter-2 inhibitors: SGLT2 inhibitors in the real world [J].
MacIsaac, Richard J. ;
Ekinci, Elif I. .
ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (23)
[22]   The effect of sodium-glucose cotransporter-2 inhibitors on cardiac structure remodeling and function: A meta-analysis of randomized controlled trials [J].
Fan, Gang ;
Guo, Dian-Long .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 114 :49-57
[23]   Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials [J].
Mantovani, Alessandro ;
Petracca, Graziana ;
Csermely, Alessandro ;
Beatrice, Giorgia ;
Targher, Giovanni .
METABOLITES, 2021, 11 (01) :1-11
[24]   Sodium-glucose cotransporter-2 inhibitors in acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials [J].
Meine, Matheus Coelho ;
Santo, Paula ;
de Oliveira, Fabiana Dolovitsch ;
Marques, Gustavo Lenci ;
Barboza, Joaquim Spadoni .
HEART FAILURE REVIEWS, 2025, 30 (01) :219-226
[25]   Risk of volume reduction associated with sodium-glucose cotransporter-2 inhibitors treatment: a meta-analysis of randomized controlled trials [J].
Rong, X., I ;
Li, X. ;
Gou, Q. ;
Chen, X. P. .
EUROPEAN HEART JOURNAL, 2020, 41 :1048-1048
[26]   Clinical implications of current cardiovascular outcome trials with sodium glucose cotransporter-2 (SGLT2) inhibitors [J].
Lim, Soo ;
Eckel, Robert H. ;
Koh, Kwang Kon .
ATHEROSCLEROSIS, 2018, 272 :33-40
[27]   Cardiovascular Outcomes With the Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes and Chronic Kidney Disease An Updated Meta-Analysis of Randomized Controlled Trials [J].
Malik, Aaqib H. ;
Yandrapalli, Srikanth ;
Goldberg, Michael ;
Jain, Diwakar ;
Frishman, William H. ;
Aronow, Wilbert S. .
CARDIOLOGY IN REVIEW, 2020, 28 (03) :116-124
[28]   The Safety and Efficacy of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in Acute Myocardial Infarction: A Systematic Review and MetaAnalysis of Randomized Controlled Trials [J].
Jafar, Uzair ;
Khan, Muhammad Sami ;
Hashmi, Tallal Mushtaq ;
Ijaz, Maryam ;
Jehangir, Hanzala ;
Jagani, Sanjna Devi ;
Munawar, Irja ;
Khalid, Ayesha ;
Maqsood, Maham ;
Akram, Muhammad Faiq ;
Saeed, Usman ;
Ahmad, Adeel .
CIRCULATION, 2024, 150
[29]   Heart Failure Prognosis in Diabetic Patients on SGLT2 (Sodium-Glucose Cotransporter-2) Inhibitors: A Systematic Review and Meta-Analysis [J].
Nso, Nso ;
Emmanuel, Kelechi ;
Nassar, Mahmoud ;
Ayinde, Hakeem .
CIRCULATION, 2021, 144
[30]   THE EFFICACY AND SAFETY OF SODIUM-GLUCOSE COTRANSPORTER 2 (SGLT2) INHIBITORS: A SYSTEMATIC REVIEW AND META-ANALYSIS [J].
Alves, C. ;
Penedones, A. ;
Mendes, D. ;
Batel Marques, F. .
CLINICAL THERAPEUTICS, 2015, 37 (08) :E123-E124
12345